Incanthera plc — Investor Relations & Filings
Incanthera plc is a therapeutics company specializing in the discovery and development of targeted solutions for dermatology and oncology. The company develops and applies sophisticated formulation and delivery technologies to create novel treatments. Its pipeline includes clinical-stage oncology assets intended for licensing to pharmaceutical partners. Incanthera has also commercialized its dermatological expertise through its direct-to-consumer skincare brand, Skin+CELL, which is designed to address unmet needs in the skincare market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Commercial Update | 2026-03-31 | English | |
| Half-year Report | 2025-12-11 | English | |
| Aquis Showcase Investor Presentation | 2025-11-17 | English | |
| AGM 2025 Presentation Materials | 2025-11-10 | English | |
| Result of AGM | 2025-11-07 | English | |
| AGM 2025 Update | 2025-11-06 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 33101940 | Commercial Update | 2026-03-31 | English | ||
|
2025
14 filings
| |||||
| 9829217 | Half-year Report | 2025-12-11 | English | ||
| 8443828 | Aquis Showcase Investor Presentation | 2025-11-17 | English | ||
| 8169884 | AGM 2025 Presentation Materials | 2025-11-10 | English | ||
| 8136371 | Result of AGM | 2025-11-07 | English | ||
| 8117602 | AGM 2025 Update | 2025-11-06 | English | ||
| 8026824 | Proactive Investor Forum Presentation | 2025-10-16 | English | ||
| 8017517 | Notice of AGM | 2025-10-14 | English | ||
| 11393901 | Investor Presentation | 2025-10-06 | English | ||
| 11392297 | Final Results | 2025-09-30 | English | ||
| 7703853 | SKIN + CELL COMMERCIAL WEBSITE NOW OPEN FOR SALES | 2025-08-11 | English | ||
| 7653380 | SKIN + CELL TO LAUNCH | 2025-08-06 | English | ||
| 6816215 | Holding(s) in Company | 2025-07-09 | English | ||
| 6524359 | Subscription, Directors' Dealing and RPT | 2025-06-30 | English | ||
| 6184237 | New Findings on Protective Effects of Skin + CELL | 2025-06-18 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Incanthera plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Incanthera plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10290/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10290 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10290 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10290 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10290}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Incanthera plc (id: 10290)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.